CACNA1G

Across TCGA pan-cancer cohorts, CACNA1G Mutation is linked to patient survival in 8 of 34 cancer types, making it a survival-associated CACNA1G data layer compared with 24 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CACNA1G Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated CACNA1G expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, SCLC, and HNSC are the cancer types where CACNA1G Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.861	0.615	<.001	32	view →
SCLC	OS	Median	II,III,IV	0.203	0.588	.005	17	view →
HNSC	OS	Median	II,III,IV	0.459	0.764	<.001	15	view →
DLBC	OS	Median	II,III,IV	0.118	0.802	.025	12	view →
KIRC	DFS	Median	IV	0.037	0.632	<.001	12	view →
LIHC	DFS	Median	III,IV	0.040	0.361	<.001	6	view →
STAD	OS	Median	All	0.434	0.671	.049	3	view →
LUSC	DFS	Median	II,III,IV	0.199	0.748	.006	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

CACNA1G–UCEC (DFS)

Open the UCEC breakdown →